NPM1 mutation but not RUNX1 mutation or multilineage dysplasia defines a prognostic subgroup within de novo acute myeloid leukemia lacking recurrent cytogenetic abnormalities in the revised 2016 WHO Classification

Documenti analoghi

• Association of mutations with morphological dysplasia in de novo acute myeloid leukemia without 2016 WHO Classification-defined cytogenetic abnormalities
  di: Weinberg, Olga K., et al.
  Pubblicazione: (2018)
• Blast phenotype and comutations in acute myeloid leukemia with mutated NPM1 influence disease biology and outcome
  di: Mason, Emily F., et al.
  Pubblicazione: (2019)
• Development of multilineage adult hematopoiesis in the zebrafish with a runx1 truncation mutation
  di: Sood, Raman, et al.
  Pubblicazione: (2010)
• In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline
  di: Mendler, Jason H., et al.
  Pubblicazione: (2013)
• The NPM1 Mutation Type Has No Impact on Survival in Cytogenetically Normal AML
  di: Pastore, Friederike, et al.
  Pubblicazione: (2014)